Jama Author Interviews: Covering Research In Medicine, Science, & Clinical Practice. For Physicians, Researchers, & Clinician

Informações:

Sinopsis

Engaging and topical conversations with authors of research, clinical reviews, and opinion pieces published in JAMA. Subscribe for the latest information, ideas, and innovations in clinical medicine and health policy.

Episodios

  • Medicare’s Historic Prescription Drug Price Negotiations

    07/11/2023 Duración: 15min

    JAMA Senior Editor Kristin Walter, MD, MS, and Lawrence O. Gostin, JD, JAMA Legal and Global Health Correspondent and Faculty Director of the O’Neill Institute for National and Global Health Law at Georgetown University, discuss the Inflation Reduction Act, which for the first time allows the Centers for Medicare & Medicaid Services to negotiate prescription drug prices with drug manufacturers. Related Content: Medicare’s Historic Prescription Drug Price Negotiations

  • Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart

    24/10/2023 Duración: 19min

    JAMA Executive Editor Gregory Curfman, MD, speaks with Richard G. Bach, MD, professor of medicine and medical director of the cardiac intensive care unit at the Washington University School of Medicine in St Louis, about the use of traditional Chinese medicine to treat patients with acute ST-segment elevation myocardial infarction. Related Content: Traditional Chinese Medicine Meets Evidence-Based Medicine in the Acutely Infarcted Heart

  • Optical Coherence Tomography (OCT): Imaging Modalities in Clinical Practice

    17/10/2023 Duración: 11min

    Optical coherence tomography (OCT) is a powerful imaging tool used across multiple clinical disciplines. JAMA Executive Editor Gregory Curfman, MD, speaks with 2023 Lasker Award recipient James G. Fujimoto, PhD, professor of electrical engineering at MIT, about his role in developing OCT and OCT’s advancements in clinical practice. Related Content: Optical Coherence Tomography—History, Evolution, and Future Prospects

  • Nasal Iodophor vs Nasal Mupirocin With Chlorhexidine Baths to Prevent Infections in Adult ICUs

    10/10/2023 Duración: 13min

    Nasal mupirocin plus chlorhexidine baths in ICUs prevents methicillin-resistant Staphylococcus aureus (MRSA) infections but raises concern about antibiotic resistance. JAMA Senior Editor Kristin Walter, MD, speaks with Susan Huang, MD, of University of California, Irvine, about a study comparing iodophor vs mupirocin with chlorhexidine bathing for ICU-attributable S aureus clinical cultures. Related Content: Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs

  • Is Remote Ischemic Conditioning (RIC) an Effective Treatment for Acute Stroke?

    03/10/2023 Duración: 11min

    It’s been unclear whether remote ischemic conditioning (RIC) with transient cycles of limb ischemia and reperfusion is an effective treatment for acute stroke. JAMA Deputy Editor Chris Muth, MD, speaks with author Rolf Blauenfeldt, MD, Aarhus University Hospital, Denmark, about the RESIST randomized clinical trial, which looks at the effect of RIC when initiated in the prehospital setting. Related Content: Remote Ischemic Conditioning for Acute Stroke

  • The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children

    26/09/2023 Duración: 14min

    During the COVID-19 pandemic, the incidence of diabetes in childhood increased. JAMA Associate Editor Anne R. Cappola, MD, ScM, and Ezio Bonifacio, PhD, from the Center for Regenerative Therapies at the Dresden University of Technology, discuss SARS-CoV-2 infection and its association with islet autoimmunity in early childhood. Related Content: SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood

  • Two-Year Outcomes After Minimally Invasive Surfactant Therapy

    19/09/2023 Duración: 15min

    Many premature infants with respiratory distress are now supported with continuous positive airway pressure, or CPAP, rather than intubation and ventilation, and those with CPAP can receive surfactant via a minimally invasive approach. JAMA Associate Editor Tracy Lieu, MD, speaks with author Peter Dargaville, MD, from the Menzies Institute for Medical Research in Tasmania, Australia, about Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial. Related Content: Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants

  • Sedentary Behavior and Dementia

    12/09/2023 Duración: 10min

    There is an established link between sedentary behavior and cardiovascular disease, but the association between sedentary behavior and dementia is unclear. JAMA Deputy Editor Christopher C. Muth, MD, speaks with David A. Raichlen, PhD, University of Southern California, about a new study that investigates the relationship between sedentary behavior and dementia in older adults. Related Content: Sedentary Behavior and Incident Dementia Among Older Adults

  • Psilocybin for Major Depressive Disorder

    31/08/2023 Duración: 28min

    In a new study, psilocybin showed promise as a treatment for major depressive disorder (MDD). JAMA Associate Editor Donald C. Goff, MD, speaks with author Charles L. Raison, MD, from the Usona Institute, about the study, as well as Rachel Yehuda, PhD, Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies. Related Content: Single-Dose Psilocybin Treatment for Major Depressive Disorder Psychedelic Therapy—A New Paradigm of Care for Mental Health

  • Neurodevelopmental Effects of Antenatal IV Magnesium Sulfate Between 30-34 Weeks' Gestation

    15/08/2023 Duración: 13min

    Magnesium sulfate is widely recommended for neuroprotection in pregnancies at risk of preterm delivery. However, the optimal gestational age for use is unclear. JAMA Associate Editor Melissa Simon, MD, MPH, and Caroline Crowther, MD, Liggins Institute, University of Auckland, discuss the use of magnesium sulfate at different gestational ages and potential benefit vs harms as reflected in the MAGENTA Trial. Related Content: Prenatal Intravenous Magnesium at 30-34 Weeks’ Gestation and Neurodevelopmental Outcomes in Offspring

  • Atorvastatin to Reduce Risk of Anthracycline-Associated Cardiac Dysfunction

    08/08/2023 Duración: 18min

    Anthracyclines are used to treat a variety of cancers, but treatment may be limited by cardiac toxicity. JAMA Executive Editor Gregory Curfman, MD, discusses a new clinical trial on the use of atorvastatin to prevent anthracycline-induced cardiac toxicity with authors Tomas Neilan, MD, MPH, and Marielle Scherrer-Crosbie, MD, PhD. Related Content: Atorvastatin for Anthracycline-Associated Cardiac Dysfunction

  • Cardiovascular Health Counseling in Pregnant and Postpartum Individuals

    25/07/2023 Duración: 18min

    Cardiovascular health is essential to everyone, but especially important to address in individuals who can become or who are pregnant or postpartum. JAMA Associate Editor Melissa Simon, MD, MPH, and Sadiya S. Khan, MD, MSc, Northwestern University, discuss the importance of cardiovascular health in pregnancy-capable, pregnant, and postpartum persons, how to counsel such individuals, issues of access to care and health equity, and their impact on cardiovascular health. Related Content: Trends in Cardiovascular Health Counseling Among Postpartum Individuals

  • Genomic Sequencing for Ill Newborns

    11/07/2023 Duración: 19min

    The performance of whole-genome sequencing in comparison with targeted genomic testing methods is not well understood. In this podcast, JAMA Associate Editor W. Gregory Feero, MD, PHD, interviews author Jill L. Maron, MD, MPH, of the Women and Infants Hospital of Rhode Island about a study of whole-genome sequencing vs a commercially available targeted genetic testing platform for diagnosing ill neonates with suspected genetic conditions. Related Content: Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder

  • Bempedoic Acid in Statin-Intolerant Patients

    11/07/2023 Duración: 16min

    Bempedoic acid is an effective option for some statin-intolerant patients with an elevated predicted risk of cardiovascular events. However, as JAMA Executive Editor Gregory Curfman, MD, discusses with editorialist Dhruv S. Kazi, MD, MSc, MS, bempedoic acid should not be considered a substitute for statins, which remain the first-line therapy for primary prevention. Related Content: Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease

  • Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus Disease in High-Risk Kidney Transplant Recipients

    03/07/2023 Duración: 17min

    Valganciclovir is standard cytomegalovirus (CMV) prophylaxis in high-risk kidney transplant recipients, but its use is limited by myelosuppression. JAMA Deputy Editor Preeti Malani, MD, MSJ, interviews Ajit Limaye, MD, from the University of Washington, about a multinational randomized trial of letermovir vs valganciclovir for CMV prevention in CMV-negative patients receiving a kidney from a CMV-positive donor. Related Content: Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients

  • The Costs of Quality Reporting

    27/06/2023 Duración: 23min

    US hospitals report data on numerous quality metrics to government and independent rating organizations, but the cost of doing so is not well known. JAMA Associate Editor Karen E. Joynt Maddox, MD, discusses a new study that examines just how many quality metrics hospitals have to report, and attempts to quantify how much data collection and reporting costs in hours and dollars, with corresponding author Stephen A. Berry MD, PhD, Johns Hopkins University, Baltimore, Maryland. Related Content: The Volume and Cost of Quality Metric Reporting

  • USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults

    23/06/2023 Duración: 24min

    Interview with Michael Silverstein, MD, MPH, USPSTF chair and coauthor of Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statements. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Anxiety Screening Depression and Suicide Risk Screening Screening for Depression and Suicide Risk in Adults Screening for Anxiety Disorders in Adults Screening for Depression and Suicide Risk in Adults Screening for Anxiety Disorders in Adults Are There Reasons to Fear Anxiety Screening? Reframing the Key Questions Regarding Screening for Suicide Risk

  • Mortality and Years of Potential Life Lost in the US Black Population

    22/06/2023 Duración: 23min

    The US Black population experienced more than 80 million excess years of life lost compared with the White population over a recent 22-year period. JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, discusses the research that quantified this disparity with authors César Caraballo, MD, Harlan M. Krumholz, MD, SM, and Clyde W. Yancy, MD, MSc. Related Content: Excess Mortality and Years of Potential Life Lost Among the Black Population in the US, 1999-2020

  • Legal Risks of Abortion Miscoding

    13/06/2023 Duración: 20min

    Intentional miscoding of abortion services may put clinicians and hospital systems at legal risk. JAMA Senior Editor Linda Brubaker, MD, MS, and Carmel Shachar, JD, MPH, from the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School, discuss the risks of intentional miscoding practices and possible penalties. Related Content: Abortion Miscoding—Legal Risks for Clinicians and Hospital Systems

  • Physician as Writer: Abraham Verghese Reflects on the Art of the Craft of Writing Fiction

    26/05/2023 Duración: 19min

    The Covenant of Water, Stanford University professor Dr Abraham Verghese’s long-awaited follow-up to his 2009 novel Cutting for Stone, traces the lives of a family in southern India negotiating forces of history, fate, and a genetic condition that takes the life of a member in each generation by drowning. In part 2, JAMA Arts and Medicine Section Editor Michael Berkwits, MD, MSCE, talks with Dr Verghese about the craft of writing fiction, the role of the humanities in medicine, of artificial intelligence in literature, and more. Related Content: “The Art of the Craft,” From The Covenant of Water The Covenant of Water – Reflections on Fiction, the Humanities, and Medicine (Part 1 of this interview)

página 2 de 40